ÂÜÀòÂÒÂ×

Gwen Melincoff holds a Master's degree in Management from Penn State Great Valley and has experience in various leadership roles within the biopharmaceutical industry. Currently, Gwen serves as a Member of the Board of Directors at Gain Therapeutics, Protalix Biotherapeutics, and Collegium Pharmaceutical, Inc. Additionally, Gwen is the Chief Business Advisor at HighTide Therapeutics and a Member of the Advisory Board at Verge Genomics.